Anbio Biotechnology (NNNN)
NASDAQ: NNNN · Real-Time Price · USD
34.25
+2.16 (6.73%)
At close: Jan 7, 2026, 4:00 PM EST
33.59
-0.66 (-1.93%)
After-hours: Jan 7, 2026, 7:38 PM EST

Anbio Biotechnology Revenue

Anbio Biotechnology had revenue of $4.58M in the half year ending June 30, 2025, with 49.85% growth. This brings the company's revenue in the last twelve months to $6.92M, down -27.17% year-over-year. In the year 2024, Anbio Biotechnology had annual revenue of $8.19M with 21.95% growth.

Revenue (ttm)
$6.92M
Revenue Growth
-27.17%
P/S Ratio
212.18
Revenue / Employee
$256,302
Employees
27
Market Cap
1.50B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20248.19M1.47M21.95%
Dec 31, 20236.71M-16.83M-71.49%
Dec 31, 202223.54M19.12M431.67%
Dec 31, 20214.43M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition